Sign in
Companies / SOLV vs BDX

SOLV vs BDX: Solventum and Becton Dickinson

Medical Devices
Compare more companies

Solventum (SOLV) reported $8.3B in revenue against a 18.7% net margin, while Becton Dickinson (BDX) reported $21.8B at a 7.7% net margin, most recently.

MetricSOLVBDX
Revenue$8.3B$21.8B
Net Income$1.6B$1.7B
Gross Margin53.5%45.4%
Operating Margin26.2%11.8%
EPS (Diluted)$8.88$5.82
Free Cash Flow$-10.0M$2.7B
Total Debt$5.0B$19.2B
P/E Ratio8.9×32.2×
P/B Ratio2.7×n/m
Stock Price$87.11$211.95
Fiscal yearFY2022FY2023FY2024FY2025
SOLV Revenue$8.1B$8.2B$8.3B$8.3B
BDX Revenue$18.9B$19.4B$20.2B$21.8B

More on SOLV

More on BDX

Other comparisons